Company: ANIX
Filing Date: 2025-05-28
Form Type: 10-Q
Source: 0001641172-25-012701
Chunk: 19

Company: Anixa Biosciences Inc
Filing Date: 2025-05-28
Form: 10-Q
Item: Part I, Item 8
Chunk 19
---
     643  
     1,026  
     1,491  
     2,154 
  
    Other 
     8  
     21  
     24  
     29 
  
    Total 
    $2,015  
    $2,207  
    $4,346  
    $4,556 
  
    Operating costs and expenses excluding non-cash stock-based compensation 
    $2,015  
    $2,207  
    $4,346  
    $4,556 

    April 30,  2025  
    October 31,  2024 
  
    Total assets: 

    Cancer Vaccines 
    $11,446  
    $12,917 
  
    CAR-T Therapeutics 
     5,433  
     8,535 
  
    Other 
     98  
     139 
  
    Total 
    $16,977  
    $21,591 
  
    Total assets 
    $16,977  
    $21,591 

Operating costs and expenses excluding non-cash stock-based compensation
is the measurement the chief operating decision-maker uses in managing the enterprise.

16

Item 2. Management’s Discussion and Analysis
of Financial Condition and Results of Operations.

Information included in this Quarterly
Report on Form 10-Q (this “Report”) contains forward-looking statements within the meaning of Section 27A of the Securities
Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking
statements are not statements of historical facts, but rather reflect our current expectations concerning future events and results. We
generally use the words “believes,” “expects,” “intends,” “plans,” “anticipates,”
“likely,” “will” and similar expressions to identify forward-looking statements. Such forward-looking statements,
including those concerning our expectations, involve risks, uncertainties and other factors, some of which are beyond our control, which
may cause our actual results, performance or achievements, or industry results, to be materially different from any future results, performance
or achievements expressed or implied by such forward-looking statements. These risks, uncertainties and factors include, but are not limited
to, those factors set forth in our Annual Report on Form 10-K for the fiscal year ended October